News about "clinical development "

Verismo Therapeutics Completes Merger to Accelerate Clinical Development

Verismo Therapeutics Completes Merger to Accelerate Clinical Development

The merger will accelerate the clinical development of SynKIR™-110 and SynKIR™-310 for solid tumor and blood cancer patients, respectively, solidifying Verismo's and HLB Group's collective mission to advance its innovative KIR-CAR platform for patients worldwide.

Clinical Development | 21/12/2024 | By Aishwarya 156

Allink Biotherapeutics Secures USD 42 Million Series A Financing Round

Allink Biotherapeutics Secures USD 42 Million Series A Financing Round

The financing round was led by Lanchi Ventures, a preeminent global early-stage technology investor known for backing breakthrough innovations, with participation from an elite syndicate of new investors.

Clinical Development | 02/12/2024 | By Aishwarya

BioMarin Strengthens its Leadership with New Appointments

BioMarin Strengthens its Leadership with New Appointments

At BioMarin, he will assume responsibility for the company's R&D organization, including discovery research, preclinical, translational and clinical programs, as well as global regulatory and medical affairs.

Clinical Development | 22/08/2024 | By Aishwarya 144

AusperBio Receives USD 37 Million in Series A Financing Round

AusperBio Receives USD 37 Million in Series A Financing Round

AusperBio Therapeutics, Inc. and Ausper Biopharma Co., Ltd. has announced the completion of a USD 37 million Series A financing round.

Clinical Development | 16/07/2024 | By Aishwarya 170

Syngene Rolls Out New Platform for Enhanced Protein Production

Syngene Rolls Out New Platform for Enhanced Protein Production

Syngene International Ltd. has introduced its new protein production platform.

Clinical Development | 05/06/2024 | By Aishwarya 242

CASI Pharmaceuticals Advances CID-103 into Clinical Development for Chronic Immune Thrombocytopenia

CASI Pharmaceuticals Advances CID-103 into Clinical Development for Chronic Immune Thrombocytopenia

CASI received a letter from the FDA indicating clearance for the study to proceed, signaling regulatory approval for the advancement of CID-103 into clinical trials.

Clinical Development | 16/05/2024 | By Abha 115

Athira Pharma Announces Appointment of Javier San Martin as Chief Medical Officer

Athira Pharma Announces Appointment of Javier San Martin as Chief Medical Officer

Athira Pharma, Inc. has appointed Javier San Martin, MD, as Chief Medical Officer.

Clinical Development | 16/04/2024 | By Aishwarya 200


 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members